Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

141
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
141
Hazard Ratio01:12

Hazard Ratio

124
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
124
Survival Curves01:18

Survival Curves

159
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
159
Multiple Comparison Tests01:13

Multiple Comparison Tests

3.9K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study.

BMJ open·2026
Same author

Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis.

Journal of comparative effectiveness research·2025
Same author

Large-scale Empirical Identification of Candidate Comparators for Pharmacoepidemiological Studies.

Drug safety·2025
Same author

Disentangling minimum clinically important difference for an individual and a population in the treatment of Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)·2025
Same author

Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study.

Pharmaceutical statistics·2025
Same author

Developing a multivariable prediction model to support personalized selection among five major empirically-supported treatments for adult depression. Study protocol of a systematic review and individual participant data network meta-analysis.

PloS one·2025

Related Experiment Video

Updated: Jul 5, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

526

Visualizing the target estimand in comparative effectiveness studies with multiple treatments.

Gabrielle Simoneau1, Marian Mitroiu2, Thomas Pa Debray3,4

  • 1Biogen Canada, Toronto, ON, Canada.

Journal of Comparative Effectiveness Research
|January 23, 2024
PubMed
Summary

Propensity score matching in real-world studies can limit external validity. New visualization tools help clarify target populations and improve interpretation of treatment effects in comparative effectiveness research.

Keywords:
comparative effectivenessmatchingmultiple sclerosispropensity scorevisualization

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

Related Experiment Videos

Last Updated: Jul 5, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

526
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

Area of Science:

  • Real-world data analysis
  • Comparative effectiveness research
  • Biostatistics

Background:

  • Propensity score matching is common in real-world comparative effectiveness research to control for confounding.
  • However, treatment effect estimates derived from these methods may lack external validity.
  • Clarifying the target estimand is crucial for accurate interpretation.

Purpose of the Study:

  • To demonstrate how differences in covariate distributions affect the external validity of treatment effect estimates.
  • To introduce two novel visualization tools for clarifying target estimands.
  • To assess the effectiveness of teriflunomide, dimethyl fumarate, and natalizumab on manual dexterity in multiple sclerosis patients.

Main Methods:

  • A simulation study was conducted to illustrate the impact of covariate distribution differences on external validity.
  • Bivariate ellipses and joy plots were employed as visualization tools.
  • A case study involving multiple sclerosis patients compared three treatments: teriflunomide (TERI), dimethyl fumarate (DMF), and natalizumab (NAT).

Main Results:

  • Simulation results showed significant variation in treatment effect estimates depending on the target population.
  • Visualizations revealed that covariate distributions differ across treatment comparisons, precluding a single common treatment effect.
  • In the case study, DMF and NAT appeared more effective than TERI for manual dexterity, but DMF vs. NAT effectiveness varied by target estimand.

Conclusions:

  • Visualization tools can enhance clarity regarding the target population in comparative effectiveness studies.
  • These tools aid in resolving ambiguity in the interpretation of estimated treatment effects.
  • Improved interpretation is vital for robust real-world evidence generation.